Rohto Pharmaceutical Co Ltd
TSE:4527
Rohto Pharmaceutical Co Ltd
TSE:4527
Price:
3 064 JPY
-0.49%
Market Closed
Updated:
May 5, 2024
Rohto Pharmaceutical Co Ltd
Net Income (Common)
|
Rohto Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
4911
4927
4452
F
4921
4967
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Net Income (Common)
¥30.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
|
Shiseido Co Ltd
TSE:4911
|
Net Income (Common)
¥21.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Net Income (Common)
¥9.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Kao Corp
TSE:4452
|
Net Income (Common)
¥43.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
|
F
|
Fancl Corp
TSE:4921
|
Net Income (Common)
¥7.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Net Income (Common)
¥20.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
See Also
What is Rohto Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
30.9B
JPY
30.9B
JPY
Based on the financial report for Dec 31, 2023, Rohto Pharmaceutical Co Ltd's Net Income (Common) amounts to 30.9B JPY.
What is Rohto Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%
13%
Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Rohto Pharmaceutical Co Ltd have been 32% over the past three years , 25% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
